Target intelligence / Profile preview

HECT domain and RLD 2 pseudogene

Molecular classification
Other (pseudogene)
01

Overview

The HECT domain and RLD 2 pseudogene (ENSG00000254398; LOC100419574) is classified as a pseudogene, meaning it is a nonfunctional segment of DNA that resembles a functional gene but typically lacks the ability to encode a functional protein product[2]. Pseudogenes are generally considered genomic relics; however, in some cases, they may serve regulatory roles—such as generating noncoding RNAs that can influence the expression of related genes—but there is no specific evidence that this pseudogene has such a function[1][2]. This entry is not a canonical therapeutic target like a receptor, enzyme, transporter, or transcription factor. There is nothing indicating that it plays a direct role in drug action, disease, or as a clinical biomarker. Its presence in genomic databases is for reference and does not mark it as functionally relevant to current pharmacological or clinical practice.

Other names
LOC100419574hect domain and RLD 2 pseudogeneENSG00000254398
02

Biological functions

Potential noncoding RNA regulation (general pseudogene property; some pseudogenes can exert regulatory effects through RNA)
03

Disease associations

Other (pseudogenes can be deregulated in diseases such as cancer in some cases, but no known role for this specific pseudogene)

Beyond the preview

Go deeper on HECT domain and RLD 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HECT domain and RLD 2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call